Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Acta Anaesthesiol Scand. 2012 Mar;56(3):382-7. doi: 10.1111/j.1399-6576.2011.02614.x. Epub 2012 Jan 4.
Dexmedetomidine (DMT) has been shown to prolong spinal anaesthesia. We evaluated the effects of intravenous DMT on low-dose bupivacaine spinal anaesthesia in elderly patients.
Fifty-one elderly patients undergoing transurethral resection of the prostate were randomized into two groups receiving either 1.0 μg/kg DMT (DMT group, n = 26) or normal saline (control group n = 25) intravenously prior to spinal anaesthesia with 1.2 ml of bupivacaine, 5 mg/ml.
The mean time to two-segment regression (39 min vs. 78 min for cold, 41 min vs. 61 min for pinprick) and that to motor regression (23 min vs. 46 min) were longer in the DMT group than in the control group. The atropine-requiring bradycardia was more frequent in the DMT group than in the control group (24.0% vs. 3.8%). The median sedation scores (ranges) during surgery were 4 (2-6) in the DMT group and 2 (1-3) in the control group (P < 0.001). Two patients in the DMT group showed oxygen desaturation (peripheral oxygen saturation < 90%) during surgery. The duration of post-operative care unit stay was longer in the DMT group than in the control group (58 min vs. 96 min). Post-operative pain intensity was lower and the mean time to first request for post-operative analgesia was longer in the DMT group compared to the control group (6.6 h vs. 2.1 h).
Intravenous DMT prolonged the duration of spinal anaesthesia and improved post-operative analgesia. However, more profound sedation with desaturation was observed with more frequent bradycardia, and delayed recovery should be considered in elderly patients.
右美托咪定(DMT)已被证明可延长椎管内麻醉的时间。我们评估了静脉内给予 DMT 对接受小剂量布比卡因椎管内麻醉的老年患者的影响。
51 例接受经尿道前列腺切除术的老年患者随机分为两组,分别在椎管内麻醉时给予 1.0μg/kg DMT(DMT 组,n=26)或生理盐水(对照组,n=25)。两组患者均接受 1.2ml 5mg/ml 布比卡因麻醉。
DMT 组冷觉和痛觉的双节段阻滞消退时间(39 分钟 vs. 78 分钟,41 分钟 vs. 61 分钟)以及运动阻滞消退时间(23 分钟 vs. 46 分钟)均长于对照组。DMT 组需要使用阿托品的心动过缓更为常见(24.0% vs. 3.8%)。DMT 组术中镇静评分中位数(范围)为 4(2-6),对照组为 2(1-3)(P<0.001)。DMT 组有 2 例患者术中出现氧饱和度下降(外周血氧饱和度<90%)。DMT 组术后监护病房停留时间长于对照组(58 分钟 vs. 96 分钟)。DMT 组术后疼痛强度较低,首次要求术后镇痛的时间较长(6.6 小时 vs. 2.1 小时)。
静脉内给予 DMT 可延长椎管内麻醉时间,并改善术后镇痛效果。然而,在老年患者中,DMT 可能会导致更明显的镇静作用和血氧饱和度下降,心动过缓更频繁,恢复时间可能会延迟。